The pharmaceutical landscape for diabetes is changing, and transdermal GLP-1 delivery systems represent a promising breakthrough. Unlike subcutaneous injections, this approach offers a simpler way to deliver GLP-1 https://denisowuu134365.activosblog.com/39578159/glp-1-patches-a-novel-approach-to-diabetes-management